secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001683168-25-002294
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals posts updated investor presentation with no material new information
--------------------------------------------------------------------------------

- Filed updated investor presentation as of April 7, 2025, under Item 8.01.
- Presentation contains only standard disclaimers and forward-looking statements; no new financial or operational data disclosed.
- No changes to guidance, product pipeline, revenue, or other key metrics were reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825002294/0001683168-25-002294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825002294/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-002294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer